Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28742942 | 0.80 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2MEN1KMT2ATHRA | |
| SCHEMBL11114858 | 0.69 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL10767930 | 0.68 | CA1 (0.34) | ALDH1A1SMN1; SMN2MEN1KMT2ATHRA | |
| SCHEMBL9580817 | 0.67 | ALDH1A1 (0.43) | ALDH1A1MEN1KMT2A | |
| SCHEMBL11407591 | 0.67 | THRA (0.46) | ALDH1A1SMN1; SMN2MEN1KMT2ATHRA | |
| SCHEMBL10691210 | 0.67 | LTA4H (0.37) | ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL2290336 | 0.66 | THRA (0.47) | THRATHRB | |
| SCHEMBL16575433 | 0.64 | HSD17B10 (0.32) | — | |
| SCHEMBL94853 | 0.64 | CA1 (0.32) | — | |
| SCHEMBL28382790 | 0.64 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116529280-A | Method for preparing a low density spray polyurethane foam for thermal insulation, sound dampening and air tightness of a building envelope | 豪瑞科技有限公司 | 2023-08-01 | — | — | CN | claimed |
| EP-4204469-A1 | PROCESS FOR MAKING LOW DENSITY SPRAY POLYURETHANE FOAM FOR INSULATION, SOUND ABATEMENT, AND AIR SEALING OF BUILDING ENCLOSURES | Holcim Technology Ltd (CH) | 2023-07-05 | — | — | EP | claimed |
| US-20220064478-A1 | PROCESS FOR MAKING LOW DENSITY SPRAY POLYURETHANE FOAM FOR INSULATION, SOUND ABATEMENT, AND AIR SEALING OF BUILDING ENCLOSURES | SES FOAM, LLC (US) | 2022-03-03 | — | — | US | claimed |
| US-8138232-B2 | Mixture of polymers containing polystyrene; mixing with solvent; precipitation; separation | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2012-03-20 | — | — | US | claimed |
| EP-1888677-B1 | METHOD FOR RECYCLING PLASTICS AND USE THEREOF | FRAUNHOFER GES FORSCHUNG (DE) | 2010-08-04 | — | — | EP | claimed |
| EP-1311599-B1 | METHOD FOR SEPARATING AND RECOVERING TARGET POLYMERS AND THEIR ADDITIVES FROM A MATERIAL CONTAINING POLYMERS AND USE THEREFORE | FRAUNHOFER GES FORSCHUNG (DE) | 2010-08-04 | — | — | EP | claimed |
| EP-2134174-A1 | THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT | Santen Pharmaceutical Co., Ltd (JP) | 2009-12-23 | — | — | EP | claimed |
| US-20080281002-A1 | Method for Recycling Plastic Materials and Use Thereof | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2008-11-13 | — | — | US | claimed |
| WO-2008130520-A1 | THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT | SANTEN PHARMACEUTICAL CO., LTD (JP) | 2008-10-30 | — | — | WO | claimed |
| US-20040229965-A1 | Method for separating and recovering target polymers and their additives from a material containing polymers | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-11-18 | — | — | US | claimed |
| US-20030191202-A1 | Preferential precipitation; reuse of plastics | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E. V. (DE) | 2003-10-09 | — | — | US | claimed |
| EP-1311599-A1 | METHOD FOR SEPARATING AND RECOVERING TARGET POLYMERS AND THEIR ADDITIVES FROM A MATERIAL CONTAINING POLYMERS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2003-05-21 | — | — | EP | claimed |
| EP-0798291-B1 | NOVEL 1,3-DIALKYLUREA DERIVATIVES | SANTEN PHARMACEUTICAL CO LTD (JP) | 2002-09-11 | — | — | EP | claimed |
| WO-2002014413-A1 | METHOD FOR SEPARATING AND RECOVERING TARGET POLYMERS AND THEIR ADDITIVES FROM A MATERIAL CONTAINING POLYMERS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-02-21 | — | — | WO | claimed |
| US-5968980-A | ENDOPEPTIDASE 24.11 INHIBITORS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1999-10-19 | — | — | US | claimed |
| EP-0798291-A1 | NOVEL 1,3-DIALKYLUREA DERIVATIVES | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1997-10-01 | — | — | EP | claimed |
| US-5296600-A | Antitumor agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-03-22 | — | — | US | claimed |
| US-4210583-A | FAST DYEINGS ON POLYESTERS AND THEIR BLENDS WITH COTTON | BASF AKTIENGESELLSCHAFT (DE) | 1980-07-01 | — | — | US | claimed |
| US-20230285261-A1 | FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR | JPMORGAN CHASE BANK, N.A. | 2023-09-14 | — | — | US | disclosed |
| US-4210583-A | FAST DYEINGS ON POLYESTERS AND THEIR BLENDS WITH COTTON | BASF AKTIENGESELLSCHAFT (DE) | 1980-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230285261-A1 | FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR | OR51E2, TRPA1, FAM120A | ALDH1A1 1958/4885SMN1; SMN2 3308/4885MEN1 3300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.